Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

about

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

Item

http://www.wikidata.org/entity/Q52721837

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

@en

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

@nl

type

Item

label

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

@en

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

@nl

prefLabel

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

@en

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.

@nl

P1476

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection

@en

P2093

Ian Williams

http://www.w3.org/2001/XMLSchema#string

Isabela Pedroza-Pacheco

http://www.w3.org/2001/XMLSchema#string

Pierre Pellegrino

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes

Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia.

NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs

Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy.

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

P304

474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.00474

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Persephone Borrow

Mala K Maini

D Peppa

P577

2018-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29616021

http://www.w3.org/2001/XMLSchema#string

P932

5864861

http://www.w3.org/2001/XMLSchema#string